Wolfe Research downgraded Fortive from Outperform to Peer Perform
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/9/2025 | $67.00 | Outperform → Neutral | Exane BNP Paribas |
| 12/9/2024 | $92.00 → $86.00 | Buy → Neutral | Citigroup |
| 11/18/2024 | Buy → Hold | Argus | |
| 11/13/2024 | $84.00 | Neutral | UBS |
| 10/10/2024 | $90.00 → $92.00 | Neutral → Overweight | JP Morgan |
| 9/6/2024 | $80.00 → $90.00 | Neutral → Outperform | Mizuho |
| 9/6/2024 | Outperform → Peer Perform | Wolfe Research | |
| 9/6/2024 | $89.00 | Overweight | Morgan Stanley |